Advisory Services Network’s TherapeuticsMD TXMD Stock Holding History

Advisory Services Network’s Portfolio TXMD Stock Details TXMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$8	Buy	+4	New	+$9	﹤0.01%	4817
2025 Q4	–	Sell	-14	Closed	-$15	–	4091
2025 Q3	$15	Buy	+14	New	+$16	﹤0.01%	4498
2021 Q1	–	Sell	-10	Closed	-$1K	–	2829
2020 Q4	$1K	Hold	10	–	–	﹤0.01%	3200
2020 Q3	$1K	Buy	+10	New	+$797	﹤0.01%	3415
2020 Q2	–	Sell	-10	Closed	-$1K	–	2623
2020 Q1	$1K	Hold	10	–	–	﹤0.01%	2945
2019 Q4	$1K	Hold	10	–	–	﹤0.01%	3015
2019 Q3	$1K	Hold	10	–	–	﹤0.01%	2753
2019 Q2	$1K	Buy	+10	New	+$1.79K	﹤0.01%	2751
2018 Q2	–	Sell	-20	Closed	-$5K	–	2693
2018 Q1	$5K	Buy	+20	New	+$5.61K	﹤0.01%	2137
2017 Q2	–	Sell	-3	Closed	-$1K	–	2377
2017 Q1	$1K	Buy	+3	New	+$928	﹤0.01%	2132

Other funds holding TXMD

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return

SCM

Squadron Capital Management Westmont, Illinois $273M AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Advisory Services Network's TXMD Position: Q1 2026 in Review

Advisory Services Network opened a new position in TherapeuticsMD (TXMD) in Q1 2026: 4 shares worth $8. The stake represents ﹤0.01% of the portfolio and ranks #4817 among its holdings. This is a return to the name: Advisory Services Network previously reported a position in TXMD as recently as Q3 2025.

Advisory Services Network first reported a position in TXMD in Q1 2017 and has held it in 10 quarters since. The position peaked at $5K in Q1 2018. 49 funds tracked by Wall St. Rank hold TXMD as of Q1 2026.

Advisory Services Network held 4 shares of TherapeuticsMD worth $8 as of Q1 2026.
TherapeuticsMD was a new Advisory Services Network position in Q1 2026.
TherapeuticsMD made up ﹤0.01% of Advisory Services Network's portfolio in Q1 2026, its #4817 holding.
Advisory Services Network first reported a position in TherapeuticsMD in Q1 2017 and has held it in 10 quarters since.
Advisory Services Network's TherapeuticsMD position peaked at $5K in Q1 2018.
49 funds tracked by Wall St. Rank held TherapeuticsMD as of Q1 2026.

Based on Advisory Services Network's 13F filing for Q1 2026, filed 15 May 2026.